SCHEMBL18681306

SCHEMBL18681306

C[C@@H](Cc1ncco1)NC(=O)OC(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA7 P43166 2/20 0.40
CTSS P25774 3/20 0.40
CTSK P43235 3/20 0.40
ITGB3 P05106 1/20 0.40
ITGA2B P08514 1/20 0.40
ATM Q13315 2/20 0.40
KMT2A Q03164 2/20 0.39
MAPT P10636 1/20 0.38
TRPA1 O75762 1/20 0.38
CTSL P07711 1/20 0.38
CTSB P07858 1/20 0.38
TSHR P16473 2/20 0.38
HSD17B10 Q99714 2/20 0.38
ALDH1A1 P00352 2/20 0.38
LMNA P02545 2/20 0.37
ACACB O00763 2/20 0.37
MEN1 O00255 1/20 0.37
PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30801969 0.84 ITGB3 (0.51) CTSSCTSKITGB3ITGA2BCTSL
SCHEMBL16487110 0.84 ATM (0.41) CA1CA2CA7CTSSCTSK
SCHEMBL25277595 0.84 ITGB3 (0.51) CTSSCTSKITGB3ITGA2BCTSL
SCHEMBL30802009 0.83 KLK5 (0.44) CTSSCTSKITGB3ITGA2BKMT2A
SCHEMBL25268638 0.83 KLK5 (0.44) CTSSCTSKITGB3ITGA2BKMT2A
SCHEMBL17275351 0.81 NPC1 (0.40) KMT2ATSHRLMNAACACB
SCHEMBL30801968 0.79 CTSK (0.38) CTSSCTSKITGB3ITGA2BCTSL
SCHEMBL4154646 0.77 L3MBTL1 (0.43) CA1CA2LMNAHTTNPSR1
SCHEMBL9303530 0.76 ATM (0.39) CA1CA2CA7CTSSCTSK
SCHEMBL17891334 0.75 TRPA1 (0.41) CA1CA2CA7CTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10392422-B2 Macrocyclic broad spectrum antibiotics RQX PHARMACEUTICALS, INC. (US) 2019-08-27 US disclosed
US-10351595-B2 2019-07-16 US disclosed
US-20170088582-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS, INC. (US) 2017-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10351595-B2 MRPL21, PRSS1, PEPD CA1 3613/4885CA2 3717/4885CA7 4377/4885
US-10392422-B2 Macrocyclic broad spectrum antibiotics MRPL21, PEPD, CTSC CA1 4337/4885CA2 4501/4885CA7 4578/4885
US-20170088582-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS MRPL21, PEPD, CTSC CA1 4337/4885CA2 4501/4885CA7 4578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.